Gindy; Marian

Patent Applications and Registrations

Patent applications and USPTO patent grants for Gindy; Marian.The latest application filed is for "lipid nanoparticle vaccine adjuvants and antigen delivery systems".

Company Profile

5.11.16

Gindy; Marian - North Wales PA
Gindy; Marian - Haledon NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Lipid nanoparticle vaccine adjuvants and antigen delivery systems Grant 11,406,706 - Gindy , et al. August 9, 2	2022-08-09
Composite flash-precipitated nanoparticles Grant 11,376,225 - Prud'homme , et al. July 5, 2	2022-07-05
Lipid Nanoparticle Vaccine Adjuvants And Antigen Delivery Systems App 20210002813 - Gindy; Marian ; et al.	2021-01-07
Lipid nanoparticle vaccine adjuvants and antigen delivery systems Grant 10,821,175 - Gindy , et al. November 3, 2	2020-11-03
Liposomal Formulations for Allosteric AKT Inhibitors App 20190374468 - Smith; Michael Hughes ; et al.	2019-12-12
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Inter App 20190330639 - Brown; Duncan ; et al.	2019-10-31
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 10,246,714 - Brown , et al.	2019-04-02
Composite Flash-precipitated Nanoparticles App 20180243229 - Prud'homme; Robert K. ; et al.	2018-08-30
Composite flash-precipitated nanoparticles Grant 9,943,490 - Prud'homme , et al. April 17, 2	2018-04-17
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20180030454 - Brown; Duncan ; et al.	2018-02-01
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 9,850,491 - Brown , et al. December 26, 2	2017-12-26
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20170029824 - Brown; Duncan ; et al.	2017-02-02
Lipid Nanoparticle Vaccine Adjuvants And Antigen Delivery Systems App 20160361411 - Gindy; Marian ; et al.	2016-12-15
Liposomal Formulations for Allosteric AKT Inhibitors App 20160317444 - Smith; Michael Hughes ; et al.	2016-11-03
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (SINA) Grant 9,447,420 - Brown , et al. September 20, 2	2016-09-20
Rna Interference Mediated Inhibition Of Catenin (cadherin-associated Protein), Beta 1 (ctnnb1) Gene Expression Using Short Interfering Nucleic Acid (sina) App 20140343126 - Brown; Duncan ; et al.	2014-11-20
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 8,835,623 - Brown , et al. September 16, 2	2014-09-16
RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA) App 20130324588 - Brown; Duncan ; et al.	2013-12-05
RNA interference mediated inhibition of catenin (cadherin-associated protein), beta 1 (CTNNB1) gene expression using short interfering nucleic acid (siNA) Grant 8,518,907 - Brown , et al. August 27, 2	2013-08-27
RNA Interference Mediated Inhibition of Catenin (Cadherin-Associated Protein), Beta 1 (CTNNB1) Gene Expression Using Short Interfering Nucleic Acid (siNA) App 20130137752 - Brown; Duncan ; et al.	2013-05-30
Nanoparticles For Photodynamic Therapy App 20110022129 - Prud'homme; Robert K. ; et al.	2011-01-27
Composite Flash-Precipitated Nanoparticles App 20100330368 - Prud'homme; Robert K. ; et al.	2010-12-30

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.